A new drug for the treatment of Bekhterev's disease is successfully undergoing the third phase of clinical trials. This was announced by the director of the Nasonova Research Institute of Rheumatology, Corresponding Member of the Russian Academy of Sciences Alexander Lila.
Such a drug was developed by the domestic company «Biocad» and has been undergoing clinical trials for several years. Today, we are completing the second phase, the third phase is underway, and in these two phases, more than 600 patients in the Russian Federation are already receiving this drug.
The drug is prescribed to patients who have not undergone treatment using genetic engineering therapy. Currently, four medical centers in Moscow, St. Petersburg and Novosibirsk are conducting such therapy in hospitals.
The drug is administered intravenously via a drip. The second infusion — drug administration — is carried out three months after the first, and then every six months. Treatment can continue for several years, but patients can lead a full life.
Bekhterev's disease — is a chronic disease of the spine and joints. Its main symptoms are: lower back pain, which worsens at night and in the morning, and stiffness of movements. Most often, the disease affects young men, the exact cause of the disease is unknown, a key role is played by genetic predisposition.
Read more materials on the topic:
- An analogue of a foreign drug for the treatment of thrombosis was created at SibGMU
- The first domestic analogue of the American drug against head cancer "Cetuximab" received registration from the Ministry of Health
- AI for diagnosing brain tumors was created by scientists from NNSU
Now on home
120-ton structure installed in 4 hours
Developed polymer biomaterials can become the basis for implants
The weight of the assembled product reaches about 25 tons, and its height is 2.5 meters
The marketplace orders domestic Kvadra Tau mini computers for testing
In 2025, the company's revenue decreased 32 times
The greatest interest was aroused by products that had been tested in combat conditions
We are talking about parked cars that advertise goods or services
The increase in emergency situations has forced airlines to look for alternatives
The X-cross 7 is almost sold out, but the X-cross 8 can still be found on sale
Method for lightweight machine learning systems will improve the efficiency of quantum key distribution
Irkutsk Aviation Plant (IAZ) is introducing new milling workshops for titanium aircraft parts
Awaiting New Contracts for Su-57 Fighters, Kalibr Missiles, and Air Defense Systems for the Middle East